BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10132391)

  • 41. The appropriateness of oral fluoroquinolone-prescribing in the long-term care setting.
    Pickering TD; Gurwitz JH; Zaleznik D; Noonan JP; Avorn J
    J Am Geriatr Soc; 1994 Jan; 42(1):28-32. PubMed ID: 8277111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ciprofloxacin drug utilization review and prospective drug use evaluation.
    Goldman MP
    DICP; 1990 Jan; 24(1):82-6. PubMed ID: 2301191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cephalosporins: use review and cost analysis.
    Noel MW; Paxinos J
    Am J Hosp Pharm; 1978 Aug; 35(8):933-5. PubMed ID: 677139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cost of outpatient physicians' services at a Veterans Administration hospital.
    Reilly PC; Reilly MC
    Ann Intern Med; 1980 Jul; 93(1):128-32. PubMed ID: 6994533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Show me the money: long-term financial impact of an antimicrobial stewardship program.
    Beardsley JR; Williamson JC; Johnson JW; Luther VP; Wrenn RH; Ohl CC
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):398-400. PubMed ID: 22418636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Streamlining outpatient drug therapy at a Veterans Affairs medical center.
    Davis AS; Wingfield CL; Forrester CW; Guthrie MK; McNew JL
    Am J Health Syst Pharm; 1997 Dec; 54(23):2719-20. PubMed ID: 9408518
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of a clinical video telehealth pain management clinic.
    Desko L; Nazario M
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):359-66. PubMed ID: 25383664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reducing cost in a teaching hospital by requiring justification for the use of vecuronium bromide.
    Blakely M; Artman M
    Am J Hosp Pharm; 1994 Oct; 51(19):2422-4. PubMed ID: 7847410
    [No Abstract]   [Full Text] [Related]  

  • 49. Sustained savings from a longitudinal cost analysis of an internet-based preapproval antimicrobial stewardship program.
    Sick AC; Lehmann CU; Tamma PD; Lee CK; Agwu AL
    Infect Control Hosp Epidemiol; 2013 Jun; 34(6):573-80. PubMed ID: 23651887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and cost of hospital admissions secondary to drug interactions involving theophylline.
    Hamilton RA; Gordon T
    Ann Pharmacother; 1992 Dec; 26(12):1507-11. PubMed ID: 1482803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of therapeutic interchange with standard educational tools for influencing fluoroquinolone prescribing.
    Goldwater SH; Milkovich G; Morrison AJ; Lindgren B
    Am J Health Syst Pharm; 2001 Sep; 58(18):1740-5. PubMed ID: 11571817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outpatient care costs.
    White RE
    Ann Intern Med; 1981 Jan; 94(1):136-7. PubMed ID: 7004299
    [No Abstract]   [Full Text] [Related]  

  • 53. Assessment of methods and outcomes: using modified inpatient ciprofloxacin criteria in community-based drug use evaluation.
    Rovers JP; Bjornson DC
    Ann Pharmacother; 1994 Jun; 28(6):714-9. PubMed ID: 7919556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of routine urinalysis and urine culture testing in an ambulatory urology clinic: a quality improvement initiative in a Veterans healthcare facility.
    Richards KA; Cesario S; Lim AH; Best SL; Deeren SM; Bushman W; Safdar N
    Can J Urol; 2017 Feb; 24(1):8627-8633. PubMed ID: 28263127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Activity-based cost model applied to tracer cardiovascular diseases].
    Marteau SA; Perego LH
    Salud Publica Mex; 2001; 43(1):32-40. PubMed ID: 11270282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic use of albumin: 2.
    Alexander MR; Alexander B; Mustion AL; Spector R; Wright CB
    JAMA; 1982 Feb; 247(6):831-3. PubMed ID: 7057567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementing an automatic fluoroquinolone therapeutic interchange program in a community hospital.
    Mioduch HJ
    Hosp Formul; 1992 Sep; 27(9):943-4, 947. PubMed ID: 10128743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "Top 5" lists top $5 billion.
    Kale MS; Bishop TF; Federman AD; Keyhani S
    Arch Intern Med; 2011 Nov; 171(20):1856-8. PubMed ID: 21965814
    [No Abstract]   [Full Text] [Related]  

  • 59. Antibiotic therapeutic interchange program: six years of experience.
    Frighetto L; Nickoloff D; Jewesson P
    Hosp Formul; 1995 Feb; 30(2):92-3, 97-8, 100 passim. PubMed ID: 10140352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Costing shared care.
    Buckingham K; Drummond N; Cameron I; Meldrum P; Douglas G
    Health Serv Manage; 1994 Feb; 90(2):22-5. PubMed ID: 10134424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.